XML 100 R80.htm IDEA: XBRL DOCUMENT
v3.22.2

Share Based Payment (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
Summary of Number and Weighted Average Exercise Price of Share Options | The number and weighted average exercise price of share options under MMT ESOP plan are as follows:
|  | Weighted Average Exercise Price per share (USD) |  |  | Number of Options |  |  | Weighted Average Exercise Price per share (USD) |  |  | Number of Options |  |  | Weighted Average Exercise Price per share (USD) |  |  | Number of Options |
|  | For the Year Ended March 31 |
Particulars |  | 2020 |  |  | 2020 |  |  | 2021 |  |  | 2021 |  |  | 2022 |  |  | 2022 |
Outstanding at beginning of the year |  |  | 1.98 |  |  |  | 17,839 |  |  |  | 1.98 |  |  |  | 17,839 |  |  |  | 1.98 |  |  |  | 17,839 |
Exercised during the year |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1.98 |  |  |  | (17,839 | )
Outstanding at the end of the year |  |  | 1.98 |  |  |  | 17,839 |  |  |  | 1.98 |  |  |  | 17,839 |  |  |  | — |  |  |  | — |
Exercisable at the end of the year |  |  | 1.98 |  |  |  | 17,839 |  |  |  | 1.98 |  |  |  | 17,839 |  |  |  | — |  |  |  | — |
Summary of Measurement Used to Determine Fair Values of ESOPs | Inputs for Measurement of Grant Date Fair Values of ESOPs
|  | For the Year Ended March 31 |
Fair value of ESOP and assumptions |  | 2020 |
Share price at grant date (USD) |  |  | 2,302 |
Fair value at grant date (USD) |  | 722 - 1,014 |
Exercise price (USD) |  |  | 2,229 |
Expected volatility |  | 43.8% - 49.0% |
Expected term |  | 3-5 years |
Expected dividends |  |  | — |
Risk-free interest rate |  |  | 1.5 | %
Summary of Number and Weighted Average Exercise Price of Employee Stock Options under Bona Vita ESOP | The number and weighted average exercise price of employee stock options under the Bona Vita ESOP Plan are as follows:
|  | Weighted Average Exercise Price per share (USD) |  |  | Number of Awards |
|  | For the Year Ended March 31 |
Particulars |  | 2020 |  |  | 2020 |
Outstanding at beginning of the year |  |  | 0.0154 |  |  |  | 13,664 |
Forfeited and expired during the year |  |  | 0.0141 |  |  |  | (9,117 | )
Exercised during the year |  |  | 0.0141 |  |  |  | (4,547 | )
Outstanding at the end of the year |  |  | — |  |  |  | — |
Exercisable at the end of the year |  |  | — |  |  |  | — |
Restricted Stock Units [Member] |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
Summary of Terms and Conditions Relating to Grants under Share Incentive Plan | The terms and conditions relating to the RSUs grants under this Share Incentive Plan are given below:
Grant details |  | Number of instruments |  |  | Vesting conditions |  | Contractual life of RSUs
RSUs granted during the year ended March 31, 2020 |  |  | 1,334,759 |  |  | Refer notes |  | 4 – 8 years
RSUs granted during the year ended March 31, 2021 |  |  | 1,478,191 |  |  | Refer notes |  | 4 – 8 years
RSUs granted during the year ended March 31, 2022 |  |  | 2,413,442 |  |  | Refer notes |  | 4 – 9 years
Summary of Number and Weighted Average Exercise Price under Share Incentive Plan | The number and weighted average exercise price of RSUs under share incentive plan are as follows:
|  | Weighted Average Exercise Price per share (USD) |  |  | Number of Awards |  |  | Weighted Average Exercise Price per share (USD) |  |  | Number of Awards |  |  | Weighted Average Exercise Price per share (USD) |  |  | Number of Awards |
|  | For the Year Ended March 31 |
Particulars |  | 2020 |  |  | 2020 |  |  | 2021 |  |  | 2021 |  |  | 2022 |  |  | 2022 |
Outstanding at beginning of the year |  |  | 0.0005 |  |  |  | 5,734,826 |  |  |  | 0.0005 |  |  |  | 6,437,422 |  |  |  | 0.0005 |  |  |  | 5,979,731 |
Granted during the year |  |  | 0.0005 |  |  |  | 1,334,759 |  |  |  | 0.0005 |  |  |  | 1,478,191 |  |  |  | 0.0005 |  |  |  | 2,413,442 |
Forfeited and expired during the year |  |  | 0.0005 |  |  |  | (319,399 | ) |  |  | 0.0005 |  |  |  | (470,810 | ) |  |  | 0.0005 |  |  |  | (424,405 | )
Exercised during the year |  |  | 0.0005 |  |  |  | (312,764 | ) |  |  | 0.0005 |  |  |  | (1,465,072 | ) |  |  | 0.0005 |  |  |  | (523,127 | )
Outstanding at the end of the year |  |  | 0.0005 |  |  |  | 6,437,422 |  |  |  | 0.0005 |  |  |  | 5,979,731 |  |  |  | 0.0005 |  |  |  | 7,445,641 |
Exercisable at the end of the year |  |  | 0.0005 |  |  |  | 2,812,252 |  |  |  | 0.0005 |  |  |  | 3,328,012 |  |  |  | 0.0005 |  |  |  | 3,869,396 |
Employee Stock Options [Member] |
Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
Summary of Terms and Conditions Relating to Grants under Share Incentive Plan | The terms and conditions relating to the ESOPs grants under this Share Incentive Plan are given below:
Grant details |  | Number of instruments |  |  | Vesting conditions |  | Contractual life of ESOPs
ESOPs granted during the year ended March 31, 2020 |  |  | 21,588 |  |  | Refer notes |  | 4 – 7 years
Summary of Number and Weighted Average Exercise Price under Share Incentive Plan | The number and weighted average exercise price of ESOPs under share incentive plan are as follows:
|  | Weighted Average Exercise Price per ESOP (USD) |  |  | Number of Awards |  |  | Weighted Average Exercise Price per ESOP (USD) |  |  | Number of Awards |  |  | Weighted Average Exercise Price per ESOP (USD) |  |  | Number of Awards |
|  | For the Year Ended March 31 |
Particulars |  | 2020 |  |  | 2020 |  |  | 2021 |  |  | 2021 |  |  | 2022 |  |  | 2022 |
Outstanding at beginning of the year |  |  | — |  |  |  | — |  |  |  | 2,229 |  |  |  | 21,588 |  |  |  | 2,229 |  |  |  | 19,489 |
Granted during the year |  |  | 2,229 |  |  |  | 21,588 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited and expired during the year |  |  | 2,229 |  |  |  | — |  |  |  | 2,229 |  |  |  | (1,968 | ) |  |  | 2,229 |  |  |  | — |
Exercised during the year |  |  | 2,229 |  |  |  | — |  |  |  | 2,229 |  |  |  | (131 | ) |  |  | 2,229 |  |  |  | — |
Outstanding at the end of the year |  |  | 2,229 |  |  |  | 21,588 |  |  |  | 2,229 |  |  |  | 19,489 |  |  |  | 2,229 |  |  |  | 19,489 |
Exercisable at the end of the year |  |  | — |  |  |  | — |  |  |  | 2,229 |  |  |  | 6,409 |  |  |  | 2,229 |  |  |  | 12,949 |

X
- Definition The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 47 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=mmyt_RestrictedStockUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=mmyt_EmployeeStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |